Clairity Raises $43 Million in Series B to Launch First FDA-Authorized AI Platform for Breast Cancer Risk Prediction
Masimo Corporation (MASI)
Last masimo corporation earnings: 4/28 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
masimo.com/about-masimo/investors
Company Research
Source: Business Wire
With backing from leading healthcare investors, Clairity accelerates its mission to predict and prevent breast cancer and expand into cardiovascular disease BOSTON--(BUSINESS WIRE)--Clairity, Inc., an AI-driven precision health company pioneering image-based risk prediction, today announced the closing of a $43 million Series B financing. The funds will be used to commercialize the company’s product, Clairity Breast, the first FDA-authorized artificial intelligence platform that predicts a woman’s five-year risk of breast cancer directly from a routine mammogram, and to advance development of Clairity Breast 3D and Clairity Heart, Clairity’s next offering focused on predicting cardiovascular risk from the same routine imaging exam.The round was led by ACE Global Equity and Santé Ventures, with continued participation from the Breast Cancer Research Foundation (BCRF) and several new investors. The strong commitment from the syndicate reflects broad confidence in Clairity’s mission t
Show less
Read more
Impact Snapshot
Event Time:
MASI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MASI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MASI alerts
High impacting Masimo Corporation news events
Weekly update
A roundup of the hottest topics
MASI
News
- HALPER SADEH LLC ENCOURAGES MASIMO CORPORATION SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTSPR Newswire
- Masimo (NASDAQ:MASI) had its "overweight" rating reaffirmed by analysts at Wells Fargo & Company.MarketBeat
- Masimo (NASDAQ:MASI) had its price target raised by analysts at BTIG Research from $198.00 to $200.00. They now have a "buy" rating on the stock.MarketBeat
- Masimo Hosts 2025 Investor Day and Details Strategic Roadmap for Durable GrowthBusiness Wire
- Masimo (NASDAQ:MASI) had its "hold" rating reaffirmed by analysts at Needham & Company LLC.MarketBeat
MASI
Earnings
- 11/4/25 - Beat
MASI
Sec Filings
- 12/3/25 - Form 8-K
- 12/1/25 - Form 8-K
- 11/28/25 - Form 144
- MASI's page on the SEC website